心包补片扩大与主动脉瓣反流复发风险增高相关
本研究评估了227例接受主动脉瓣修复或保瓣手术患者的早晚期临床结局及失败预测因素。随访显示,复发显著主动脉瓣反流20例(8.8%),5年免于再手术率88%;术前反流程度重、瓣叶修复、欧洲心脏手术风险评估系统评分高及使用心包补片扩大是复发或再手术的预测因素。
要点
- 227例主动脉瓣修复或保瓣手术患者中,院内死亡1例(0.4%),随访死亡15例(6.6%),总体5年生存率94.4%。
- 复发显著(≥3级)主动脉瓣反流20例(8.8%),其中17例再手术,5年免于再手术率88%。
- 心包补片扩大与复发显著主动脉瓣反流或再手术相关(RR 2.34,p=0.032)。
核心结论
- 主动脉瓣修复和保瓣手术可获得良好的早晚期临床结局。
- 但作者经验中复发主动脉瓣反流率显著,尤其是使用戊二醛处理的自体心包补片行瓣叶扩大的患者。
研究设计与样本
- 2004年至2016年在本部门连续接受主动脉瓣修复或保瓣手术的227例患者。
- 81例(36%)行主动脉根部置换伴或不伴瓣叶修复,97例(42%)行升主动脉置换伴或不伴瓣叶修复,49例(22%)行孤立主动脉瓣修复。
- 临床和超声心动图随访完整。
主要发现
- 院内死亡1例(0.4%)。
- 临床随访平均69±40个月(范围1至147个月),超声心动图随访平均53±40个月(范围1至147个月)。
- 随访期间死亡15例(6.6%),总体5年生存率94.4%。
- 复发显著(≥3级)主动脉瓣反流20例(8.8%),其中17例行再手术,5年免于再手术率88%。
- 复发显著主动脉瓣反流或再手术的预测因素:术前主动脉瓣反流程度较高(III至IV级 vs I至II级;相对风险[RR] 1.97;p=0.023)、瓣叶修复(RR 2.92;p=0.001)、欧洲心脏手术风险评估系统评分较高(RR 1.16;p=0.006)、使用心包补片扩大的瓣膜修复(RR 2.34;p=0.032)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: This study assessed early and late clinical outcomes in patients who underwent aortic valve repair or an aortic valve-sparing operation and investigated predictors for failure. METHODS: Of 227 consecutive patients who underwent aortic valve repair or a valve-sparing operation in our department between 2004 and 2016, 81 (36%) underwent aortic root replacement with or without cusp repair, 97 (42%) ascending aorta replacement with or without cusp repair, and 49 (22%) isolated aortic valve repair. Clinical and echocardiographic follow-up was complete. RESULTS: One patient (0.4%) died in-hospital. Mean clinical and echocardiographic follow-up was 69 ± 40 months (range, 1 to 147 months) and 53 ± 40 months (range, 1 to 147 months), respectively. Fifteen patients (6.6%) died during follow-up, with an overall 5-year survival rate of 94.4%. Recurrent significant (≥3) aortic insufficiency developed in 20 patients (8.8%), 17 of whom underwent reoperation, with a 5-year freedom from reoperation rate of 88%. Predictors for recurrent significant aortic insufficiency or reoperation were greater preoperative aortic insufficiency (grade III to IV vs I to II; relative risk [RR], 1.97; p = 0.023), cusp repair (RR, 2.92; p = 0.001), higher European System for Cardiac Operative Risk Evaluation score (RR, 1.16; p = 0.006), and valve repair with pericardial patch augmentation (RR, 2.34; p = 0.032). CONCLUSIONS: Aortic valve repair and valve-sparing operations can be performed with good early and late clinical outcomes. In our experience, however, the rate of recurrent aortic insufficiency was significant, especially in patients who underwent cusp augmentation with glutaraldehyde-treated autologous pericardial patch.
引用
- Ram E, Moshkovitz Y, Shinfeld A, et al. Pericardial Patch Augmentation Is Associated With a Higher Risk of Recurrent Aortic Insufficiency. Ann Thorac Surg. 2018. PMID: 29800539. doi:10.1016/j.athoracsur.2018.04.058
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。